Cite Filings / SYRE / 0001628280-26-065249

Feed Companies Filings Check

Sign in

424B5

Prospectus

Spyre Therapeutics, Inc. Filed 2026-10-06 Acc 0001628280-26-065249

Documents 1

424B5 Prospectus , spyre-final424b5.htm

Around this filing

2026-10-09 SCHEDULE 13D/A Beneficial Ownership Report
2026-10-07 8-K Material agreement
2026-10-06 424B5 Prospectus
2026-10-05 424B5 Prospectus
2026-10-02 4 Changes in Ownership
2026-10-02 4 Changes in Ownership
2026-10-02 4 Changes in Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading spyre-final424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…